激素受体状态异质性的同步双侧乳腺癌：一例报告
Synchronous bilateral breast cancer with heterogeneous hormone receptor status: a case report.
作者信息
Luitel Prajjwol, Karki Badal, Paudel Sujan, Shrestha Asim, Pariyar Suraj, Hirachan Suzita
机构信息
Department of General Surgery, Maharajgunj Medical Campus, Institute of Medicine, Tribhuvan University, Kathmandu 44600, Nepal.
Department of General Surgery, Tribhuvan University Teaching Hospital, Maharajgunj, Kathmandu 44600, Nepal.
出版信息
J Surg Case Rep. 2024 Dec 12;2024(12):rjae786. doi: 10.1093/jscr/rjae786. eCollection 2024 Dec.
The expression of estrogen, progesterone, and HER2 receptors in breast cancer cells helps guide treatment and predict outcomes. When the status of these receptors is heterogeneous, it makes treatment planning more complex. We present the case of a 72-year-old woman with bilateral breast cancer with heterogenous receptor status and subsequent challenges in management.
雌激素、孕激素和人表皮生长因子受体2（HER2）在乳腺癌细胞中的表达有助于指导治疗并预测预后。当这些受体的状态呈异质性时，会使治疗计划变得更加复杂。我们报告了一例72岁双侧乳腺癌患者，其受体状态为异质性，以及后续管理中遇到的挑战。
Zotero 插件